AI assistant
HARVARD BIOSCIENCE INC — Director's Dealing 2021
May 27, 2021
34975_dirs_2021-05-27_d5135864-744c-4555-9f71-f2251dab8b1c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2021-05-25
Reporting Person: LOY BERTRAND (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-25 | Common Stock | A | 14400 | $0.00 | Acquired | 286826 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 68466 | Indirect |
Footnotes
F1: Represents an award of 14,400 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2021, immediately prior to the commencement of such meeting, and (ii) May 25, 2022.
F2: Includes (a) the award described in footnote (1) above, (b) an award of 15,975 remaining unvested restricted stock units vesting in equal quarterly installments on June 30, 2021, September 30, 2021 and December 31, 2021, and (c) 256,451 shares of common stock held by the Reporting Person.